About Us

About Teleflex^™ Interventional Urology

The Interventional Urology team at Teleflex is dedicated to developing innovative, minimally invasive, and clinically effective products that address unmet needs for both patients and healthcare professionals. We do this by uniting passionate people around a shared purpose to make lives better.

The UroLift™ System is a minimally invasive treatment for urinary symptoms caused by benign prostatic hyperplasia (BPH), also known as enlarged prostate. The goal of the UroLift™ System is to significantly increase the standard of care for men with BPH.

About Teleflex^™

Teleflex Incorporated is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose-driven innovation—a relentless pursuit of identifying unmet clinical needs—to benefit patients and healthcare providers.

Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine, and respiratory care.

Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, visit Teleflex.com.

Sales Terms and Conditions

Don't Miss Out – Follow Us!

Look for: UroLift System by Teleflex Interventional Urology

Follow us on social media for the latest news, articles, events, and helpful information. Click the icons below to visit our LinkedIn, Facebook, X (Twitter), and YouTube pages.

Outside of the U.S.? Search for UroLift, then select the applicable region's page: APAC (Asia-Pacifica) EMEA (Europe, Middle East), or LATAM (Latin America).